- Study shows how COVID variants evolve to achieve same goal FierceBiotech
- Study Details Immune Cells Vital to Success of Vaccines Against Coronavirus NYU Langone Health
- Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial The BMJ
- UCSF QBI, University College London, and Mount Sinai Identify Shared Molecular Mechanisms Across SARS-CoV-2 Variants that Allow Virus to Thrive Despite Vaccination Mount Sinai
- Use of kidneys from SARS-CoV-2 infected donors Nature.com
- View Full Coverage on Google News
Read original article here